Multi-agent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone and daratumumab (Pom-PAD-Dara) in relapsed/ refractory multiple myeloma
Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia